BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8635072)

  • 1. Primary hypothyroidism as a consequence of 131-I-metaiodobenzylguanidine treatment for children with neuroblastoma.
    Picco P; Garaventa A; Claudiani F; Gattorno M; De Bernardi B; Borrone C
    Cancer; 1995 Nov; 76(9):1662-4. PubMed ID: 8635072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary hypothyroidism and 131I-MIBG therapy in neuroblastoma.
    Picco P; Garaventa A; Claudiani F; Garibaldi L; Borrone C
    Lancet; 1993 Jul; 342(8862):57. PubMed ID: 8100332
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.
    Quach A; Ji L; Mishra V; Sznewajs A; Veatch J; Huberty J; Franc B; Sposto R; Groshen S; Wei D; Fitzgerald P; Maris JM; Yanik G; Hawkins RA; Villablanca JG; Matthay KK
    Pediatr Blood Cancer; 2011 Feb; 56(2):191-201. PubMed ID: 20830775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thyroid dysfunction due to 131I-metaiodobenzylguanidine in patients with neuroblastoma].
    Garrido Magaña E; Silva Estrada JA; Nishimura Meguro E; Rivera Hernández AJ; Zurita Cruz JN
    Rev Chil Pediatr; 2020 Jun; 91(3):379-384. PubMed ID: 32730518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of patients with neuroblastoma treated with 125-I MIBG.
    Sisson JC; Shapiro B; Hutchinson RJ; Shulkin BL; Zempel S
    Am J Clin Oncol; 1996 Apr; 19(2):144-8. PubMed ID: 8610638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma.
    Clement SC; van Rijn RR; van Eck-Smit BL; van Trotsenburg AS; Caron HN; Tytgat GA; van Santen HM
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):706-15. PubMed ID: 25512056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiated thyroid carcinoma after 131I-MIBG treatment for neuroblastoma during childhood: description of the first two cases.
    van Santen HM; Tytgat GA; van de Wetering MD; van Eck-Smit BL; Hopman SM; van der Steeg AF; Nieveen van Dijkum EJ; van Trotsenburg AS
    Thyroid; 2012 Jun; 22(6):643-6. PubMed ID: 22524499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: importance of continuous surveillance.
    Clement SC; van Eck-Smit BL; van Trotsenburg AS; Kremer LC; Tytgat GA; van Santen HM
    Pediatr Blood Cancer; 2013 Nov; 60(11):1833-8. PubMed ID: 23832530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.
    Klingebiel T; Treuner J; Ehninger G; Keller KD; Dopfer R; Feine U; Niethammer D
    Cancer Chemother Pharmacol; 1989; 25(2):143-8. PubMed ID: 2598401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during (131)I-meta-iodobenzylguanidine treatment in children with neuroblastoma.
    van Santen HM; de Kraker J; van Eck BL; de Vijlder JJ; Vulsma T
    Cancer; 2002 Apr; 94(7):2081-9. PubMed ID: 11932913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.
    Sisson JC; Shapiro B; Hutchinson RJ; Zasadny KR; Mallette S; Mudgett EE; Wieland DM
    J Nucl Biol Med (1991); 1991; 35(4):255-9. PubMed ID: 1823830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma.
    Hutchinson RJ; Sisson JC; Shapiro B; Miser JS; Normole D; Shulkin BL; Francis IR; Zasadny K; Carey JE; Johnson JW
    Am J Clin Oncol; 1992 Jun; 15(3):226-32. PubMed ID: 1590275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.
    De Kraker J; Hoefnagel CA; Caron H; Valdés Olmos RA; Zsiros J; Heij HA; Voûte PA
    Eur J Cancer; 1995; 31A(4):600-2. PubMed ID: 7576977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.
    Voûte PA; Hoefnagel CA; de Kraker J; Valdes Olmos R; Bakker DJ; van de Kleij AJ
    Prog Clin Biol Res; 1991; 366():439-45. PubMed ID: 2068157
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved radiation protection of the thyroid gland with thyroxine, methimazole, and potassium iodide during diagnostic and therapeutic use of radiolabeled metaiodobenzylguanidine in children with neuroblastoma.
    van Santen HM; de Kraker J; van Eck BL; de Vijlder JJ; Vulsma T
    Cancer; 2003 Jul; 98(2):389-96. PubMed ID: 12872361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
    van Hasselt EJ; Heij HA; de Kraker J; Vos A; Voûte PA
    Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
    Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary ovarian insufficiency in children after treatment with 131I-metaiodobenzylguanidine for neuroblastoma: report of the first two cases.
    Clement SC; Kraal KC; van Eck-Smit BL; van den Bos C; Kremer LC; Tytgat GA; van Santen HM
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E112-6. PubMed ID: 24187404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine.
    Sisson JC; Shapiro B; Hutchinson RJ; Carey JE; Zasadny KR; Zempel SA; Normolle DP
    Eur J Nucl Med; 1994 Jan; 21(1):46-52. PubMed ID: 8088285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.
    Matthay KK; Huberty JP; Hattner RS; Ablin AR; Engelstad BL; Zoger S; Hasegawa BH; Price D
    J Nucl Biol Med (1991); 1991; 35(4):244-7. PubMed ID: 1823827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.